We recently reported claims that the DEA has granted unnamed private pharmaceutical companies license to grow cannabis for experimental purposes. Now, the Sacramento News & Review on Dec. 19 cites a report from the Union of Medical Marijuana Patients to the effect that the United States government holds a patent on the use of cannabinoids as "antioxidants and neuroprotectants"—specifically, the Department of Health & Human Services holds Patent #6630507, as documented at the US Patent & Trademark Office.
Recent comments
3 days 14 hours ago
1 week 4 days ago
1 week 4 days ago
22 weeks 4 days ago
26 weeks 5 days ago
28 weeks 2 days ago
28 weeks 3 days ago
40 weeks 5 days ago
46 weeks 3 days ago
1 year 5 weeks ago